ATAI
ATAI Life Sciences N.V.

5,561
Mkt Cap
$1.57B
Volume
978,637.00
52W High
$6.75
52W Low
$1.15
PE Ratio
-5.38
ATAI Fundamentals
Price
$4.43
Prev Close
$4.33
Open
$4.35
50D MA
$4.88
Beta
1.37
Avg. Volume
4.88M
EPS (Annual)
-$0.932
P/B
6.52
Rev/Employee
$5,703.70
Loading...
Loading...
News
all
press releases
Enhanced Fortifies Executive Leadership Team & Board of Directors
Enhanced Fortifies Executive Leadership Team & Board of Directors Enhanced Fortifies Executive Leadership Team & Board of Directors PR Newswire NEW YORK, Nov. 19, 2025 Co-Founder Maximilian Martin...
PR Newswire·22d ago
News Placeholder
More News
News Placeholder
atai Life Sciences (ATAI) Upgraded to Buy: Here's Why
atai Life Sciences (ATAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·2mo ago
News Placeholder
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year?
Here is how atai Life Sciences N.V. (ATAI) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
Zacks·3mo ago
News Placeholder
atai Life Sciences (ATAI) Upgraded to Buy: Here's What You Should Know
atai Life Sciences (ATAI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·3mo ago
News Placeholder
Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year?
Here is how Halozyme Therapeutics (HALO) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.
Zacks·3mo ago
News Placeholder
Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now
atai Life Sciences (ATAI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks·4mo ago
News Placeholder
atai Life Sciences (ATAI) Upgraded to Strong Buy: Here's Why
atai Life Sciences (ATAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks·5mo ago
News Placeholder
Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?
Here is how atai Life Sciences N.V. (ATAI) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
Zacks·5mo ago
News Placeholder
5 Biotech Stocks with Highly Anticipated Pending Results
Biotech M&A is heating up, making small-cap firms with breakthrough assets top acquisition targets and potential big winners for investors.
Stocktwits Contributor·6mo ago
News Placeholder
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year?
Here is how atai Life Sciences N.V. (ATAI) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
Zacks·6mo ago

Latest ATAI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.